HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$1.17
Day range
$1.06 - $1.19
Year range
$1.01 - $14.45
Market cap
79.71M USD
Avg Volume
884.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 26.86M | — |
Operating expense | 72.98M | 7.44% |
Net income | -47.47M | 22.07% |
Net profit margin | -176.71 | — |
Earnings per share | -0.61 | 26.05% |
EBITDA | -45.80M | 32.24% |
Effective tax rate | 0.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 371.08M | -23.16% |
Total assets | 430.34M | -22.00% |
Total liabilities | 93.15M | -18.50% |
Total equity | 337.19M | — |
Shares outstanding | 71.81M | — |
Price to book | 0.25 | — |
Return on assets | -26.17% | — |
Return on capital | -29.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -47.47M | 22.07% |
Cash from operations | -39.70M | 2.21% |
Cash from investing | 32.28M | 176.75% |
Cash from financing | 0.00 | — |
Net change in cash | -7.42M | 91.02% |
Free cash flow | -5.52M | 72.85% |
About
Founded
2014
Website
Employees
166
